A new contender has emerged in the domain of pain-focused biotechnology, marking...
Denali and Sanofi have been working together since 2018, when they reached an ag...
In a chain of unfolding events reminiscent of the tumbling of dominos, Gilead Sc...
RioDerm-001 is under clinical development by Rion and currently in Phase II for ...
SY-001 is under clinical development by CellOrigin Technology (Hangzhou) and cur...
Not Disclosed Neurodegeneration is under clinical development by Eli Lilly and C...
RioDerm-004 is under clinical development by Rion and currently in Phase I for F...
Ketamine is under clinical development by NRX Pharmaceuticals and currently in P...
SAR-442970 is under clinical development by Sanofi and currently in Phase II for...
NA-921 is under clinical development by Biomed Industries and currently in Phase...
NA-921 is under clinical development by Biomed Industries and currently in Phase...
PF-07872412 is under clinical development by Pfizer and currently in Phase I for...
INV-347 is under clinical development by Inversago Pharma and currently in Phase...
Although people of European descent account for less than one-quarter of the wor...
Before statins, niacin was seen as a way to increase good cholesterol and promot...
There is still so much we don’t know about the psychiatric effects of GLP-1s.
